46 results
8-K
EX-3.2
THRX
Theseus Pharmaceuticals Inc
14 Feb 24
Completion of Acquisition or Disposition of Assets
10:44am
prior to the meeting: (a) on a reasonably accessible electronic network, provided that the information required to gain access to such list is provided … the whole time of the meeting on a reasonably accessible electronic network, and the information required to access such list shall be provided
SC TO-T/A
EX-99
Concentra Merger Sub II, Inc.
14 Feb 24
Third party tender offer statement (amended)
10:35am
, to have access during normal business hours to the books and records of Parent as may be reasonably necessary to audit the calculation of such CVR
SC TO-T/A
EX-99
Concentra Merger Sub II, Inc.
30 Jan 24
Third party tender offer statement (amended)
8:23am
. On the same day, Theseus provided certain representatives of Parent and TCP with access to the Theseus’ electronic data room. Subsequently, due … actions.
Access to Information. Except if prohibited by applicable law, during the period prior to the earlier of the Effective Time or the termination
SC 14D9
THRX
Theseus Pharmaceuticals Inc
10 Jan 24
Tender offer solicitation
9:47am
was granted access to the Company’s virtual data room, in order for Party C to perform its due diligence investigation. Subsequently, through early … into any change in control transaction. Shortly thereafter, Party A was granted access to the Company’s virtual data room, in order for Party
SC TO-T
EX-99
Concentra Merger Sub II, Inc.
10 Jan 24
Third party tender offer statement
8:51am
Agreement. On the same day, Theseus provided certain representatives of Parent and TCP with access to the Theseus’ electronic data room. Subsequently … respect, the operations of Theseus or any of its Subsidiaries; or
authorize, commit or agree to take any of the foregoing actions.
Access
8-K
EX-2.1
um1q8rmr44vn0z0h3sxu
22 Dec 23
Entry into a Material Definitive Agreement
6:36am
8-K
EX-10.2
adu2ky1z
4 Dec 23
Departure of Directors or Certain Officers
6:30am
8-K
EX-10.4
svgsb8pi 8kjrgv
4 Dec 23
Departure of Directors or Certain Officers
6:30am
8-K
EX-10.1
yt8nfrem0 nb
4 Dec 23
Departure of Directors or Certain Officers
6:30am
8-K
EX-10.3
uey2h6 b8
4 Dec 23
Departure of Directors or Certain Officers
6:30am
8-K
EX-10.2
mh06 2qoag4jy
13 Nov 23
Theseus Pharmaceuticals Announces Process to Explore Strategic Alternatives
4:06pm
8-K
EX-10.1
m6owl
13 Nov 23
Theseus Pharmaceuticals Announces Process to Explore Strategic Alternatives
4:06pm
PRE 14A
md78ny2a5qnuqomud sf
14 Apr 23
Preliminary proxy
9:00am
S-3
EX-1.2
88ox plc00piog9dongy
3 Nov 22
Shelf registration
9:06am